Project description
Mimicking nanocarriers enhancing therapeutic effectiveness in chronic inflammatory diseases
A better understanding of how nanoparticles interact with cells and their role in immunomodulation will lead to more effective therapies for chronic inflammatory diseases and advance nanomedicine. Supported by the Marie Skłodowska-Curie Actions programme, the NANO-MAC project will develop macrophage-mimicking nanocarriers (MMCs) with fusogenic properties (FMMCs) for targeted delivery of dexamethasone to inflammation sites, focusing on inflammatory bowel disease (IBD). These nanocarriers aim to enhance therapeutic effectiveness while minimising systemic side effects. The project will synthesise and optimise MMCs for better drug delivery, evaluating their biocompatibility, cytotoxicity, and immune response modulation. FMMCs will also be tested in an in vitro model for effectiveness.
Objective
In this project, we propose to develop innovative macrophage-mimicking nanocarriers (MMCs) with fusogenic properties (FMMCs) for the targeted delivery of dexamethasone to inflammation sites, particularly for treating Inflammatory Bowel Disease (IBD). These nanocarriers, designed to mimic the natural targeting abilities of macrophages, aim to enhance therapeutic efficacy and reduce systemic side effects.
To achieve this, we will first synthesize and optimize MMCs, incorporating fusogenic properties to improve cellular uptake and drug delivery efficiency. These will then be evaluated for biocompatibility, cytotoxicity, and their ability to modulate immune responses. Finally, we will test the (F)MMCs in a sophisticated in vitro model mimicking the gut-immune interface to assess their performance in a disease-relevant environment.
The successful execution of this project will not only advance the field of nanomedicine but will also contribute to a better understanding of nanoparticle-cell interactions and their potential in immunomodulation, paving the way for more effective and safer therapies for chronic inflammatory diseases.
Overall, this project will allow me to independently lead a 2-year research initiative, advancing my expertise in the field of nanomedicine and drug delivery systems, and positioning me as a mature and independent researcher capable of contributing to the development of innovative therapies for chronic inflammatory diseases.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-MSCA-2024-PF-01
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
15782 Santiago De Compostela
Spain
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.